Cargill and BASF Team Up to Produce Omega-3 Products

Cargill and BASF Plant Science will co-develop a new dietary source of EPA/DHA that will make it easier for consumers globally to achieve optimal intakes of EPA- and DHA-rich omega-3 polyunsaturated fatty acids. This next generation canola oil containing EPA/DHA will enable food, pharmaceutical and nutritional supplement manufacturers to deliver the potential health benefits of omega-3 fatty acids in a wide variety of new, cost-effective consumer products available by the end of the decade.

Although research is ongoing, a growing body of scientific evidence links dietary intake of omega-3 fatty acids with benefits for heart and brain health. However, humans on average are currently not consuming enough of these healthy fatty acids. In fact, according to the National Health and Nutrition Examination Survey (NHANES) EPA/DHA consumption in the US is less than 185mg per day. Health experts in various countries recommend intake of 250-500mg per day for positive health benefits from EPA/DHA.

Growing consumer awareness of the health benefits of omega-3 is fueling double-digit growth for omega-3 products. According to a recent report by Prepared Foods, the global market for foods, beverages and supplements incorporating omega-3s was worth nearly $7.5 billion in 2010, and is predicted to grow 15-20 percent annually through 2015.

Cargill and BASF Plant Science’s multi-year development and commercialization agreement reflects the complementary competencies that both companies bring to the partnership in the EPA/DHA canola field. Specifically, Cargill’s food applications capabilities and existing commercial relationships with major food manufacturers and food service operators globally, and BASF Plant Science’s expertise in genetically
enhancing EPA/DHA levels in canola seed oil and deregulating it for use in food products. BASF Plant Science foresees a total investment of more than 150 million euros ($208 million U.S.).

The products generated through the Cargill / BASF Plant Science collaboration will address two key issues facing companies seeking to broadly deliver omega-3s to global consumers: shelf stability and cost.